Which has the lower trailing P/E, ANAB or ETON?

ANAB has the lower trailing P/E: ANAB trades at 9.20 and ETON at 144.62. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ANAB or ETON?

Over the past five years, ETON grew revenue faster — ANAB at a 18.60% CAGR versus ETON at 47.98%.

Is ANAB or ETON more profitable?

ANAB runs the higher net margin — ANAB at 82.37% versus ETON at 12.02%.

How have ANAB and ETON total returns compared?

Over the past 5 years, ANAB delivered 21.54% and ETON delivered 63.04% annualized total return. Past performance doesn't predict future results.

AnaptysBio, Inc. (ANAB) vs Eton Pharmaceuticals, Inc. (ETON)

A side-by-side comparison of AnaptysBio, Inc. and Eton Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANAB

AnaptysBio, Inc.

$1.46B

$49.41HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT

ETON

Eton Pharmaceuticals, Inc.

$1.52B

$55.62HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ANAB vs ETON

growth of $100 · dividends reinvested · last 8y

ANAB +4.5% (+0.6%/yr)ETON +789.9% (+31.4%/yr)ETON compounded faster over this window

Log scale — wide-divergence pair

ANAB ETON

ANAB vs ETON: by the numbers

•ETON is the larger company ($1.52B vs $1.46B market cap).
•ANAB trades at the lower trailing earnings multiple (9.20 vs 144.62 P/E), one valuation lens rather than an overall verdict.
•ANAB converts more revenue to profit (82.37% vs 12.02% net margin).
•ETON grew revenue faster over the past five years (47.98% vs 18.60% CAGR).

Metrics side by side

Valuation

Metric	ANAB	ETON
P/E ratio	9.20	144.62
Forward P/E	N/A	51.14
P/S ratio	6.16	14.43
P/B ratio	138.21	32.71
EV / EBITDA	11.78	73.17
FCF yield	1.23%	0.97%

Profitability

Metric	ANAB	ETON
Gross margin	98.97%	57.87%
Operating margin	20.42%	0.09%
Net margin	82.37%	12.02%
ROE	1849.06%	27.24%
ROIC	47.55%	20.41%

Growth (annualized)

Metric	ANAB	ETON
Revenue CAGR (5Y)	18.60%	47.98%
FCF CAGR (5Y)	27.41%	N/A
Total return CAGR (5Y)	21.54%	63.04%

Frequently asked

Which has the lower trailing P/E, ANAB or ETON?: ANAB has the lower trailing P/E: ANAB trades at 9.20 and ETON at 144.62. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ANAB or ETON?: Over the past five years, ETON grew revenue faster — ANAB at a 18.60% CAGR versus ETON at 47.98%.
Is ANAB or ETON more profitable?: ANAB runs the higher net margin — ANAB at 82.37% versus ETON at 12.02%.
How have ANAB and ETON total returns compared?: Over the past 5 years, ANAB delivered 21.54% and ETON delivered 63.04% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANAB analysis Full ETON analysis Interactive comparison tool

Dig into the metrics

AnaptysBio P/E ratio Eton Pharmaceuticals P/E ratio AnaptysBio ROE Eton Pharmaceuticals ROE AnaptysBio operating margin Eton Pharmaceuticals operating margin AnaptysBio revenue growth Eton Pharmaceuticals revenue growth AnaptysBio free cash flow Eton Pharmaceuticals free cash flow

AnaptysBio & Eton Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.